Literature DB >> 32119531

Stem Cell-Derived Endothelial Cell Model that Responds to Tobacco Smoke Like Primary Endothelial Cells.

Pei-Hsuan Chu1, Guibin Chen2, David Kuo1, John Braisted1, Ruili Huang1, Yuhong Wang1, Anton Simeonov1, Manfred Boehm2, David L Gerhold1.   

Abstract

To clarify how smoking leads to heart attack and stroke, we developed an endothelial cell model (iECs) generated from human induced Pluripotent Stem Cells (iPSC) and evaluated its responses to tobacco smoke. These iECs exhibited a uniform endothelial morphology, and expressed markers PECAM1/CD31, VWF/ von Willebrand Factor, and CDH5/VE-Cadherin. The iECs also exhibited tube formation and acetyl-LDL uptake comparable to primary endothelial cells (EC). RNA sequencing (RNA-Seq) revealed a robust correlation coefficient between iECs and EC (R = 0.76), whereas gene responses to smoke were qualitatively nearly identical between iECs and primary ECs (R = 0.86). Further analysis of transcriptional responses implicated 18 transcription factors in regulating responses to smoke treatment, and identified gene sets regulated by each transcription factor, including pathways for oxidative stress, DNA damage/repair, ER stress, apoptosis, and cell cycle arrest. Assays for 42 cytokines in HUVEC cells and iECs identified 23 cytokines that responded dynamically to cigarette smoke. These cytokines and cellular stress response pathways describe endothelial responses for lymphocyte attachment, activation of coagulation and complement, lymphocyte growth factors, and inflammation and fibrosis; EC-initiated events that collectively lead to atherosclerosis. Thus, these studies validate the iEC model and identify transcriptional response networks by which ECs respond to tobacco smoke. Our results systematically trace how ECs use these response networks to regulate genes and pathways, and finally cytokine signals to other cells, to initiate the diverse processes that lead to atherosclerosis and cardiovascular disease.

Entities:  

Year:  2020        PMID: 32119531      PMCID: PMC8020615          DOI: 10.1021/acs.chemrestox.9b00363

Source DB:  PubMed          Journal:  Chem Res Toxicol        ISSN: 0893-228X            Impact factor:   3.739


  46 in total

Review 1.  The role of aryl hydrocarbon receptor in the pathogenesis of cardiovascular diseases.

Authors:  Hesham M Korashy; Ayman O S El-Kadi
Journal:  Drug Metab Rev       Date:  2006       Impact factor: 4.518

Review 2.  The CCAAT/enhancer (C/EBP) family of basic-leucine zipper (bZIP) transcription factors is a multifaceted highly-regulated system for gene regulation.

Authors:  Junichi Tsukada; Yasuhiro Yoshida; Yoshihiko Kominato; Philip E Auron
Journal:  Cytokine       Date:  2011-01-22       Impact factor: 3.861

3.  Systems biology approaches identify ATF3 as a negative regulator of Toll-like receptor 4.

Authors:  Mark Gilchrist; Vesteinn Thorsson; Bin Li; Alistair G Rust; Martin Korb; Jared C Roach; Kathleen Kennedy; Tsonwin Hai; Hamid Bolouri; Alan Aderem
Journal:  Nature       Date:  2006-05-11       Impact factor: 49.962

Review 4.  Smoking and cardiovascular disease: mechanisms of endothelial dysfunction and early atherogenesis.

Authors:  Barbara Messner; David Bernhard
Journal:  Arterioscler Thromb Vasc Biol       Date:  2014-03       Impact factor: 8.311

5.  Impact of female cigarette smoking on circulating B cells in vivo: the suppressed ICOSLG, TCF3, and VCAM1 gene functional network may inhibit normal cell function.

Authors:  Feng Pan; Tie-Lin Yang; Xiang-Ding Chen; Yuan Chen; Ge Gao; Yao-Zhong Liu; Yu-Fang Pei; Bao-Yong Sha; Yan Jiang; Chao Xu; Robert R Recker; Hong-Wen Deng
Journal:  Immunogenetics       Date:  2010-03-09       Impact factor: 2.846

6.  Mainstream smoke chemistry analysis of samples from the 2009 US cigarette market.

Authors:  J A Bodnar; W T Morgan; P A Murphy; M W Ogden
Journal:  Regul Toxicol Pharmacol       Date:  2012-06-07       Impact factor: 3.271

7.  Cyclooxygenase-2 in endothelial and vascular smooth muscle cells restrains atherogenesis in hyperlipidemic mice.

Authors:  Soon Yew Tang; James Monslow; Leslie Todd; John Lawson; Ellen Puré; Garret A FitzGerald
Journal:  Circulation       Date:  2014-02-11       Impact factor: 29.690

8.  FBI-1 functions as a novel AR co-repressor in prostate cancer cells.

Authors:  Jiajun Cui; Yutao Yang; Chuanfu Zhang; Pinliang Hu; Wei Kan; Xianhong Bai; Xuelin Liu; Hongbin Song
Journal:  Cell Mol Life Sci       Date:  2010-09-02       Impact factor: 9.207

9.  Effect of full flavor and denicotinized cigarettes exposure on the brain microvascular endothelium: a microarray-based gene expression study using a human immortalized BBB endothelial cell line.

Authors:  Pooja Naik; Ravi K Sajja; Shikha Prasad; Luca Cucullo
Journal:  BMC Neurosci       Date:  2015-06-23       Impact factor: 3.288

10.  Alterations in the expression of the NF-κB family member RelB as a novel marker of cardiovascular outcomes during acute exacerbations of chronic obstructive pulmonary disease.

Authors:  Laura Labonté; Patrick Coulombe; Michela Zago; Jean Bourbeau; Carolyn J Baglole
Journal:  PLoS One       Date:  2014-11-19       Impact factor: 3.240

View more
  3 in total

1.  The MT1G Gene in LUHMES Neurons Is a Sensitive Biomarker of Neurotoxicity.

Authors:  Zhi-Bin Tong; John Braisted; Pei-Hsuan Chu; David Gerhold
Journal:  Neurotox Res       Date:  2020-09-01       Impact factor: 3.911

Review 2.  Human Induced Pluripotent Stem Cells as a Screening Platform for Drug-Induced Vascular Toxicity.

Authors:  Chengyi Tu; Nathan J Cunningham; Mao Zhang; Joseph C Wu
Journal:  Front Pharmacol       Date:  2021-03-10       Impact factor: 5.810

Review 3.  Targeting Epigenetic Mechanisms in Vascular Aging.

Authors:  Zhongxiao Lin; Qian Ding; Xinzhi Li; Yuliang Feng; Hao He; Chuoji Huang; YiZhun Zhu
Journal:  Front Cardiovasc Med       Date:  2022-01-04
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.